Precigen PGEN
NASDAQ PGEN
$8.56 +0.51 (+6.34%)
At close: Sep 30, 2026 · 4:00 PM EDT

Precigen (PGEN) Capital Leases (2012 - 2013)

Updated

Precigen (PGEN) posted Capital Leases of $10,000 for Q4 2013, down 76.2% from $42,000 a year earlier and down 37.5% from the prior quarter.

Analysis

Precigen (PGEN) Capital Leases (2012 - 2013) Analysis & Trends

Since Q4 2012, Precigen has reported Capital Leases for 4 quarters.

  • In prior years, Precigen's Capital Leases was $42,000 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Precigen 3.06 Bn 3.06 Bn 52.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 10,000.00
Sep 30, 2013 16,000.00
Jun 30, 2013 25,000.00
Dec 31, 2012 42,000.00
API Access

Precigen Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=PGEN&period=max&api_key=YOUR_API_KEY